CEL-SCI Corporation (CVM) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

CEL-SCI Corporation (CVM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $9.7M, listed on AMEX, employing roughly 43 people, carrying a beta of 0.71 to the broader market. CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. Led by Geert R. Kersten, public since 1983-12-08.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for CVM as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →